Evidence map›Paper›PMID 37468747›Full record

ArticleThe Journal of antibiotics2023

Emblestatin: a new peptide antibiotic from Embleya scabrispora K20-0267.

Yuta Awano, Hayama Tsutsumi, Yuta Kikuchi, Aoi Kimishima, Masato Iwatsuki, Yukihiro Asami, Yuki Inahashi

Abstract read
PubMed Publisher
In one paragraph

Article in The Journal of antibiotics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuta AwanoGraduate School of Infection Control Sciences, Kitasato University, Tokyo, Japan.
Hayama TsutsumiGraduate School of Infection Control Sciences, Kitasato University, Tokyo, Japan.
Yuta KikuchiGraduate School of Infection Control Sciences, Kitasato University, Tokyo, Japan.
Aoi KimishimaGraduate School of Infection Control Sciences, Kitasato University, Tokyo, Japan.ORCID 0000-0002-2625-1356
Masato IwatsukiGraduate School of Infection Control Sciences, Kitasato University, Tokyo, Japan.ORCID 0000-0001-8373-4314
Yukihiro AsamiGraduate School of Infection Control Sciences, Kitasato University, Tokyo, Japan.ORCID 0000-0003-1821-9169
Yuki InahashiGraduate School of Infection Control Sciences, Kitasato University, Tokyo, Japan. y-ina@lisci.kitasato-u.ac.jp.

Funding

Japan Agency for Medical Research and Development (AMED) JP19am0101096Japan Agency for Medical Research and Development (AMED) JP22ama121035MEXT | Japan Society for the Promotion of Science (JSPS) 19H05685
6 · The paper itself

Abstract

A new peptide, emblestatin (1), was discovered from a culture broth of Embleya scabrispora K20-0267. This strain was isolated from soil using an agar medium containing lysozyme. Based on NMR and mass spectrometric analyses, 1 consists of 2-(2-hydroxyphenyl)-2-oxazoline, β-alanine, glutamine, N

Indexed as

Anti-Bacterial AgentsMicrobial Sensitivity TestsStaphylococcus aureusMagnetic Resonance SpectroscopyMass SpectrometryPeptidesProteus vulgarisSoil MicrobiologyAnti-Bacterial AgentsPeptides

Identifiers

PMID37468747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.